The development of a novel dry powder inhaler.

A novel active and multi-dose dry powder inhaler (DPI) was developed and evaluated to deliver a small quantity (100–500μg) of pure drug without any excipient. This dry powder inhaler utilized two compressed air flows to dispense and deliver drug powder: the primary flow aerosolizes the drug powder from its pocket and the secondary flow further disperses the aerosol.